ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,738.52
-1.78%
US Tech 100
19,624.00
-2.27%
다우존스 지수
42,579.08
-0.99%
Bitcoin
85,658.48
-4.75%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Astria Therapeutics Inc (ATXS) 시세

Astria Therapeutics Inc

Astria Therapeutics Inc (ATXS)

NASDAQ
6.42
0.19
(3.05%)
종가: 07 3월 6:00AM
15분 지연
6.42
-0.01
( -0.16% )
시간외 거래: 7:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
6.42
매수가
2.58
매도가
6.99
거래량
261,932
6.25 일간 변동폭 6.88
5.84 52주 범위 16.90
market_cap
362.308M
전일 종가
6.23
개장가
6.755
최근 거래 시간
1
@
6.54
마지막 거래 시간
재정 규모
US$ 1,726,983
VWAP
6.5933
평균 볼륨(3m)
291,660
발행 주식
56,434,219
배당수익률
-
주가수익률
-6.61
주당순이익(EPS)
-1.29
매출
-
순이익
-72.89M

Astria Therapeutics Inc 정보

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.astriatx.com
본부
Wilmington, Delaware, USA
설립됨
-
Astria Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ATXS. The last closing price for Astria Therapeutics was US$6.23. Over the last year, Astria Therapeutics shares have traded in a share price range of US$ 5.84 to US$ 16.90.

Astria Therapeutics currently has 56,434,219 shares in issue. The market capitalisation of Astria Therapeutics is US$351.59 million. Astria Therapeutics has a price to earnings ratio (PE ratio) of -6.61.

ATXS 최신 뉴스

추가 뉴스
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.081.2618296536.346.515.842520906.25221788CS
4-1.22-15.96858638747.647.6855.842175646.69870254CS
12-3.99-38.328530259410.4110.6955.842916608.00345882CS
26-5.12-44.367417677611.5412.925.843102939.79137095CS
52-7.64-54.338549075414.0616.95.8449349311.18221111CS
1560.34.901960784316.1216.92.3632862110.38970674CS
260-2.11-24.73622508798.5316.92.3629072010.28855082CS

ATXS - Frequently Asked Questions (FAQ)

What is the current Astria Therapeutics share price?
The current share price of Astria Therapeutics is US$ 6.42
How many Astria Therapeutics shares are in issue?
Astria Therapeutics has 56,434,219 shares in issue
What is the market cap of Astria Therapeutics?
The market capitalisation of Astria Therapeutics is USD 351.59M
What is the 1 year trading range for Astria Therapeutics share price?
Astria Therapeutics has traded in the range of US$ 5.84 to US$ 16.90 during the past year
What is the PE ratio of Astria Therapeutics?
The price to earnings ratio of Astria Therapeutics is -6.61
What is the reporting currency for Astria Therapeutics?
Astria Therapeutics reports financial results in USD
What is the latest annual profit for Astria Therapeutics?
The latest annual profit of Astria Therapeutics is USD -72.89M
What is the registered address of Astria Therapeutics?
The registered address for Astria Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Astria Therapeutics website address?
The website address for Astria Therapeutics is www.astriatx.com
Which industry sector does Astria Therapeutics operate in?
Astria Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
359.07M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
694.19M
LZMHLZ Technology Holdings Ltd
US$ 9.79
(33.56%)
590.39k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 14.62
(33.39%)
16.06M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
135.18M
BLNEEastside Distilling Inc
US$ 0.7846
(-89.40%)
12.01k
ACONAclarion Inc
US$ 1.5501
(-77.86%)
51.08M
ELABPMGC Holdings Inc
US$ 0.7132
(-42.02%)
1.48M
SNBRSleep Number Corporation
US$ 7.49
(-41.89%)
4.51M
CCLDCareCloud Inc
US$ 2.0904
(-33.00%)
1.22M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
690.21M
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
357.04M
NVDANVIDIA Corporation
US$ 110.57
(-5.74%)
314.33M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
134M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.75
(-11.38%)
131.63M

ATXS Discussion

게시물 보기
Monksdream Monksdream 6 월 전
ATXS under $15
👍️0
Monksdream Monksdream 8 월 전
ATXS under $10
👍️0
Monksdream Monksdream 10 월 전
ATXS under $10
👍️0
GreenStockEVs GreenStockEVs 2 년 전
NEWS OUT - Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema

About Astria Therapeutics:

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Learn more about our company on our website, www.astriatx.com.
👍️0

최근 히스토리

NASDAQ
ATXS
Astria Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지